V. Sovenko

Prospects of using immunotherapeutic approach in treatment of non-small-cell lung cancer patients

V. Orel, A. Ganul, N. Khranovskaya, 2014 .

CORRELATION OF RELAPSE-FREE SURVIVAL WITH NEOADJUVANT TREATMENT IN PATIENTS WITH STAGE IIIA NON-SMALL CELL LUNG CANCER.

A. Ganul, V. Sovenko, Kateryna A. Maliarchuk, 2022, Wiadomosci lekarskie.

Phenotypical and functional properties of generated dendritic cells in lung cancer patients

M. Inomistova, N. Khranovska, O. Skachkova, 2016 .

9057 New dendritic cell immunotherapy approach: randomized phase II study in IIB-IIIA stage non-small cell lung cancer patients

N. Khranovska, O. Skachkova, S. Zemskov, 2009 .

COMPARISON OF EARLY TREATMENT- EMERGENT COMPLICATIONS OF STAGE III A NON-SMALL CELL CARCINOMA (NSCLC STAGE III A) IN PATIENTS TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NHLT), (NCHT), AND NEOADJUVANT CHEMOTHERAPY AND ADJUVANT RADIATION THERAPY

A. Ganul, V. Sovenko, A. Shevchenko, 2023, Клінічна та профілактична медицина.

PROSPECTS OF NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER AS A METHOD OF IMPROVING SURVIVAL.

A. Ganul, V. Sovenko, Bogdan O Borisyuk, 2022, Wiadomosci lekarskie.

[About the impact of the dendritic cell autovaccine on the results of treatment of non-small-cell lung cancer patients].

A. Ganul, V. Sovenko, Ganul Vl, 2013, Likars'ka sprava.